These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 17875524)
1. Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma. Okamura J; Uike N; Utsunomiya A; Tanosaki R Int J Hematol; 2007 Aug; 86(2):118-25. PubMed ID: 17875524 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Okamura J; Utsunomiya A; Tanosaki R; Uike N; Sonoda S; Kannagi M; Tomonaga M; Harada M; Kimura N; Masuda M; Kawano F; Yufu Y; Hattori H; Kikuchi H; Saburi Y Blood; 2005 May; 105(10):4143-5. PubMed ID: 15665110 [TBL] [Abstract][Full Text] [Related]
3. Case of a patient with progressive adult T-cell leukemia/lymphoma treated successfully by reduced-intensity conditioning stem cell transplantation from an HLA-incompatible related donor. Fujiwara H; Kawada H; Matsushita K; Hamada H; Ozaki A; Inoue H; Yoshimitsu M; Kukita T; Arimura K; Ohtsubo H; Uozumi K; Arima N; Tei C Int J Hematol; 2005 Nov; 82(4):357-61. PubMed ID: 16298831 [TBL] [Abstract][Full Text] [Related]
4. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma. Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Tanosaki R; Uike N; Utsunomiya A; Saburi Y; Masuda M; Tomonaga M; Eto T; Hidaka M; Harada M; Choi I; Yamanaka T; Kannagi M; Matsuoka M; Okamura J Biol Blood Marrow Transplant; 2008 Jun; 14(6):702-8. PubMed ID: 18489996 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M; Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757 [TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Choi I; Tanosaki R; Uike N; Utsunomiya A; Tomonaga M; Harada M; Yamanaka T; Kannagi M; Okamura J; Bone Marrow Transplant; 2011 Jan; 46(1):116-8. PubMed ID: 20400987 [TBL] [Abstract][Full Text] [Related]
9. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen. Maruyama D; Fukuda T; Kato R; Yamasaki S; Usui E; Morita-Hoshi Y; Kim SW; Mori S; Heike Y; Makimoto A; Tajima K; Tanosaki R; Tobinai K; Takaue Y Biol Blood Marrow Transplant; 2007 Aug; 13(8):932-41. PubMed ID: 17640597 [TBL] [Abstract][Full Text] [Related]
10. [Adult T cell leukemia/lymphoma (ATL)]. Tanosaki R Nihon Rinsho; 2003 Sep; 61(9):1592-5. PubMed ID: 14515729 [TBL] [Abstract][Full Text] [Related]
11. The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation. Kato K; Uike N; Wake A; Yoshimitsu M; Tobai T; Sawayama Y; Takatsuka Y; Fukuda T; Uchida N; Eto T; Nakashima Y; Kondo T; Taguchi J; Miyamoto T; Nakamae H; Ichinohe T; Kato K; Suzuki R; Utsunomiya A; Hematol Oncol; 2019 Feb; 37(1):54-61. PubMed ID: 30171618 [TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission. Hirosawa M; Yamaguchi T; Tanaka A; Kominato Y; Higashi T; Morimoto H; Tsukada J Ann Hematol; 2020 Mar; 99(3):599-607. PubMed ID: 32006150 [TBL] [Abstract][Full Text] [Related]
13. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Dietrich S; Andrulis M; Hegenbart U; Schmitt T; Bellos F; Martens UM; Meissner J; Krämer A; Ho AD; Dreger P Biol Blood Marrow Transplant; 2011 Aug; 17(8):1250-4. PubMed ID: 21215813 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Nakase K; Hara M; Kozuka T; Tanimoto K; Nawa Y Bone Marrow Transplant; 2006 Jan; 37(1):41-4. PubMed ID: 16247419 [TBL] [Abstract][Full Text] [Related]
15. Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Yeshurun M; Labopin M; Blaise D; Cornelissen JJ; Sengeloev H; Vindelov L; Kuball J; Chevallier P; Craddock C; Socie G; Bilger K; Schouten HC; Fegueux N; Goker H; Maertens J; Bunjes D; Arnold R; Nagler A; Mohty M Cancer; 2014 Mar; 120(6):855-63. PubMed ID: 24338939 [TBL] [Abstract][Full Text] [Related]
16. Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy. Zell M; Assal A; Derman O; Kornblum N; Battini R; Wang Y; Narasimhulu DM; Mantzaris I; Shastri A; Verma A; Ye H; Braunschweig I; Janakiram M Oncotarget; 2016 Aug; 7(32):51981-51990. PubMed ID: 27341021 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108 [TBL] [Abstract][Full Text] [Related]